ZOGENIX, INC.
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Biopharmaceuticals
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 89.08B | ||||||
| 40.9B | ||||||
| 32.25B | ||||||
| 25.14B | ||||||
| 15.39B |
